Overview
Genomenon provides genomic intelligence platforms like Mastermind and Cancer Knowledgebase (CKB) that curate evidence from millions of full-text articles to accelerate variant interpretation for clinical diagnosis and precision medicine. These tools connect genes, variants, diseases, therapies, and clinical trials using AI and expert curation, supporting pharma R&D in identifying biomarkers and genetic drivers. They integrate with analysis software to deliver actionable insights for rare diseases, oncology, and therapeutic development.
Frequently asked questions
- What are Genomenon's key platforms and capabilities?
- Mastermind offers gene- and variant-level insights from over 11M full-text articles and 3.7M supplemental texts, using AI and expert curation for variant interpretation. Cancer Knowledgebase (CKB) interprets cancer genomic profiles with protein impact, therapies, and trials. Both support clinical decisions in rare diseases and oncology.
- How does Genomenon ensure data accuracy and currency?
- Genomenon employs genomics-focused AI to index the human genome and expert genetic scientists to curate evidence per clinical guidelines like ACMG. Content updates weekly with new peer-reviewed publications, clinical trials, and supplemental data for comprehensive, evidence-based genomic datasets.
- What integrations and geographies does Genomenon support?
- Platforms integrate with tools like Golden Helix VarSeq for unified workflows. Genomenon serves global clinicians, researchers, and pharma developers by indexing worldwide literature, with no geographic restrictions specified.